Stay updated on Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history now includes an addition of Revision: v3.4.2 and deletions of a government-funding notice and Revision: v3.4.1, which are UI/versioning updates rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide funding and operating status notice and updated the revision to v3.4.1, removing the previous v3.4.0 revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedThe history page adds a glossary toggle and legends for color-coded changes (green for additions, red for deletions) and updates the revision label to v3.4.0.SummaryDifference0.4%

- Check42 days agoChange DetectedThe history page now shows Revision: v3.3.4 in place of Revision: v3.3.3. This is a minor site version update.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page footer now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure item as well as the Revision: v3.3.2 note were removed. These changes are metadata updates and do not affect the study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision in the page history shows the site version updated from v3.2.0 to v3.3.2, a minor update with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.